These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38668590)

  • 1. Snakebites in Cameroon: Tolerance of a Snake Antivenom (Inoserp™ PAN-AFRICA) in Africa in Real-Life Conditions.
    Benhammou D; Chippaux JP; Ntone R; Madec Y; Amta P; Noel G; Karl FN; Perilhou A; Matchim L; Sanchez M; Ndifon M; Clauteaux P; Eteki L; Boum Y; Nkwescheu AS; Taieb F
    Toxins (Basel); 2024 Mar; 16(4):. PubMed ID: 38668590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of a therapeutic protocol for the management of snakebite envenomations in Benin].
    Tankpinou Zoumenou H; Chippaux JP; Fachehoun P; Priuli G; Massougbodji A
    Med Trop Sante Int; 2023 Dec; 3(4):. PubMed ID: 38390023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real life condition evaluation of Inoserp PAN-AFRICA antivenom effectiveness in Cameroon.
    Chippaux JP; Ntone R; Benhammou D; Madec Y; Noël G; Perilhou A; Karl F; Amta P; Sanchez M; Matchim L; Clauteaux P; Eteki L; Ndifon M; Boum Y; Nkwescheu AS; Taieb F
    PLoS Negl Trop Dis; 2023 Nov; 17(11):e0011707. PubMed ID: 37939111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of a new polyvalent antivenom against snakebite envenomation (Inoserp® Panafricain) in two different epidemiological settings: Northern Benin and Maritime Guinea].
    Chippaux JP; Baldé MC; Sessinou É; Yéro Boiro M; Massougbodji A
    Med Sante Trop; 2015; 25(1):56-64. PubMed ID: 25847880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa.
    Harrison RA; Oluoch GO; Ainsworth S; Alsolaiss J; Bolton F; Arias AS; Gutiérrez JM; Rowley P; Kalya S; Ozwara H; Casewell NR
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005969. PubMed ID: 29045429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Australian Snakebite Project, 2005-2015 (ASP-20).
    Johnston CI; Ryan NM; Page CB; Buckley NA; Brown SG; O'Leary MA; Isbister GK
    Med J Aust; 2017 Aug; 207(3):119-125. PubMed ID: 28764620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcomes among snakebite patients in north-west Ethiopia-A retrospective analysis.
    Steegemans I; Sisay K; Nshimiyimana E; Gebrewold G; Piening T; Menberu Tessema E; Sahelie B; Alcoba G; Gebretsadik FS; Essink D; Collin S; Lucero E; Ritmeijer K
    PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010148. PubMed ID: 35139079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antivenom use in Australia. Premedication, adverse reactions and the use of venom detection kits.
    Sutherland SK
    Med J Aust; 1992 Dec 7-21; 157(11-12):734-9. PubMed ID: 1360618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antivenom use, premedication and early adverse reactions in the management of snake bites in rural Papua New Guinea.
    Williams DJ; Jensen SD; Nimorakiotakis B; Müller R; Winkel KD
    Toxicon; 2007 May; 49(6):780-92. PubMed ID: 17210167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute adverse events associated with the administration of Crotalidae polyvalent immune Fab antivenom within the North American Snakebite Registry.
    Kleinschmidt K; Ruha AM; Campleman S; Brent J; Wax P;
    Clin Toxicol (Phila); 2018 Nov; 56(11):1115-1120. PubMed ID: 29688079
    [No Abstract]   [Full Text] [Related]  

  • 11. Moderate-to-severe
    Lamb T; Stewart D; Warrell DA; Lalloo DG; Jagpal P; Jones D; Thanacoody R; Gray LA; Eddleston M
    Clin Toxicol (Phila); 2021 Nov; 59(11):992-1001. PubMed ID: 33720783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose adrenaline, promethazine, and hydrocortisone in the prevention of acute adverse reactions to antivenom following snakebite: a randomised, double-blind, placebo-controlled trial.
    de Silva HA; Pathmeswaran A; Ranasinha CD; Jayamanne S; Samarakoon SB; Hittharage A; Kalupahana R; Ratnatilaka GA; Uluwatthage W; Aronson JK; Armitage JM; Lalloo DG; de Silva HJ
    PLoS Med; 2011 May; 8(5):e1000435. PubMed ID: 21572992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic mechanisms underlying adverse reactions induced by intravenous administration of snake antivenoms.
    León G; Herrera M; Segura Á; Villalta M; Vargas M; Gutiérrez JM
    Toxicon; 2013 Dec; 76():63-76. PubMed ID: 24055551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective, consecutive case series of 158 snakebite patients treated at Savannakhet provincial hospital, Lao People's Democratic Republic with high incidence of anaphylactic shock to horse derived F(ab')2 antivenom.
    Vongphoumy I; Chanthilat P; Vilayvong P; Blessmann J
    Toxicon; 2016 Jul; 117():13-21. PubMed ID: 26995210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical safety of a polyvalent F(ab')2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon. VAO (Venin Afrique de l'Ouest) Investigators.
    Chippaux JP; Lang J; Eddine SA; Fagot P; Rage V; Peyrieux JC; Le Mener V
    Trans R Soc Trop Med Hyg; 1998; 92(6):657-62. PubMed ID: 10326114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of snakebites by the staff of a rural clinic: the impact of providing free antivenom in a nurse-led clinic in Meserani, Tanzania.
    Yates VM; Lebas E; Orpiay R; Bale BJ
    Ann Trop Med Parasitol; 2010 Jul; 104(5):439-48. PubMed ID: 20819312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa.
    Williams DJ; Gutiérrez JM; Calvete JJ; Wüster W; Ratanabanangkoon K; Paiva O; Brown NI; Casewell NR; Harrison RA; Rowley PD; O'Shea M; Jensen SD; Winkel KD; Warrell DA
    J Proteomics; 2011 Aug; 74(9):1735-67. PubMed ID: 21640209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of fresh frozen plasma for treating venom-induced consumption coagulopathy in cases of Australian snakebite (ASP-18).
    Isbister GK; Buckley NA; Page CB; Scorgie FE; Lincz LF; Seldon M; Brown SG;
    J Thromb Haemost; 2013 Jul; 11(7):1310-8. PubMed ID: 23565941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Snakebite in northern Cameroon: 134 victims of bites by the saw-scaled or carpet viper, Echis ocellatus.
    Einterz EM; Bates ME
    Trans R Soc Trop Med Hyg; 2003; 97(6):693-6. PubMed ID: 16117965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of tolerance and effectiveness of a F(ab')(2) polyvalent antienom for African snake bites in Kindia, Guinea].
    Baldé MC; Chippaux JP; Boiro MY; Stock R; Massougbodji A
    Bull Soc Pathol Exot; 2012 Aug; 105(3):157-61. PubMed ID: 22359185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.